BIAFW Financials
bioAffinity Technologies Inc. Warrant - Financial statements & key metrics
Stock Price
$0.23
Market Cap
-
P/E Ratio
-0.3
EPS
$-0.75
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$9.36M
Gross Profit
-
Operating Income
-
Net Income
$-9.04M
EPS (Diluted)
$-0.75
Balance Sheet Highlights
Total Assets
$6.51M
Total Liabilities
$3.91M
Shareholders Equity
-
Cash & Equivalents
$1.11M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-7.26M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-158.6%
Net Margin
-217.5%
ROE
-245.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BIAFW revenue?
BIAFW's most recent quarterly revenue was $9.36M. Annual revenue can be calculated by summing the four most recent quarters.
Is BIAFW profitable?
BIAFW reported a loss of $9.04M in the most recent quarter. The net profit margin is -217.5%.
What is BIAFW market cap?
Market cap data for BIAFW is available above.
Does BIAFW have debt?
View BIAFW's balance sheet for debt information.
What is BIAFW cash flow?
Cash flow data is available in the full financial statements.